Trial intelligence / Profile preview

Simbrinza as Adjunctive Therapy to Prostaglandin Analogue in Glaucoma

NCT01937312Phase 4Completed

Sponsor
Alcon Inc.
Start
Oct 2013
Primary completion
May 2014
01

Overview

A Phase 4 trial of brinzolamide + brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Oct 2013; status: completed.

02

Drugs

brinzolamide + brimonidine
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT01937312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01937312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call